E.S. Barr & Co’s CVS Health CVS Stock Holding History

E.S. Barr & Co’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,725	Closed	-$613K	–	113
2025 Q4	$613K	Buy	+7,725	New	+$609K	0.03%	73

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

E.S. Barr & Co's CVS Position: Q1 2026 in Review

E.S. Barr & Co sold out of CVS Health (CVS) in Q1 2026, closing a stake of 7,725 shares — an estimated $613K sold.

E.S. Barr & Co first reported a position in CVS in Q4 2025 and held it in 1 quarter. The position peaked at $613K in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

E.S. Barr & Co reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
E.S. Barr & Co sold 7,725 CVS Health shares in Q1 2026, an estimated $613K.
E.S. Barr & Co first reported a position in CVS Health in Q4 2025 and held it in 1 quarter.
E.S. Barr & Co's CVS Health position peaked at $613K in Q4 2025.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on E.S. Barr & Co's 13F filing for Q1 2026, filed 13 May 2026.